GeneOne Life Science, Inc. (KRX:011000)
South Korea · Delayed Price · Currency is KRW 869.00
+60.00 (7.42%)
At close: May 7, 2026
GeneOne Life Science Market Cap
GeneOne Life Science has a market cap or net worth of 73.35 billion as of May 7, 2026. Its market cap has decreased by -52.61% in one year.
Market Cap
73.35B
Enterprise Value
104.58B
Revenue
23.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
869.00
Market Cap Chart
Since August 30, 1995, GeneOne Life Science's market cap has increased from 3.40B to 73.35B, an increase of 2,057.50%. That is a compound annual growth rate of 10.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 78.80B | -52.79% |
| Dec 30, 2025 | 166.91B | -1.14% |
| Dec 30, 2024 | 168.84B | -24.04% |
| Dec 28, 2023 | 222.27B | -59.85% |
| Dec 29, 2022 | 553.65B | -55.74% |
| Dec 30, 2021 | 1.25T | 30.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 170.43B |
| Vaxcell-Bio Therapeutics | 164.20B |
| ENCell | 164.03B |
| Amicogen | 120.12B |
| iNtRON Biotechnology | 107.49B |
| Prestige BioPharma | 98.68B |
| Oncocross | 96.47B |
| IMB Dx | 94.34B |